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1ST ASIA PACIFIC AKI CRRT 2017adjusted accordingly to achieve normalization of thyroid function over
months. She underwent 3 sessions of hemodialysis during her hospi-
talization. Her renal function improved to normal after 11 months of
thyroxine replacement (Figure 1). Thyroid peroxidase and thyroglob-
ulin antibodies were strongly positive at 849 IU/ml and 7730 IU/ml
respectively. A very high level of TSH and reduced free T4 conﬁrm
primary hypothyroidism and antithyroid antibody proﬁle was
compatible with autoimmune thyroiditis.
Conclusion: Clinical signs and symptoms of hypothyroidism can be
subtle in patient with chronic kidney disease (CKD). In our case, pre-
existing CKD and severely deranged renal function are suggestive of
end stage renal disease. Therefore, attending physicians should have a
high index of suspicion for hypothyroidism as thyroid hormone
replacement can result in complete renal recovery. Thyroid function
should be assessed in patients with unexpected deterioration of renal
function including those with underlying CKD.
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Introduction: Accurate assessment of glomerular ﬁltration rate (GFR) in
ICU patients is very important for institution of supportive therapy,
preventive therapy, early renal support, drug dosing modiﬁcation or
avoidance of nephrotoxic drugs. Kinetic estimate of GFR (keGFR) takes
into account the changes of creatinine over time, creatinine production
rate, and the volume of distribution, hence postulated to be a more
accurate estimate of GFR in the acute setting, where there are rapidly
changing kidney functions as in the critically ill. We evaluated theKidney International Reports (2017) 2, S1–S41association of the keGFR with estimated GFR (eGFR) by conventional
method.
Methods: This is an interim analysis of a single centre, prospective
observational study of critically ill patients. The study has been
registered with the National Medical Research Register (NMRR-14-
1897-21447) and has obtained ethics approval. Inclusion criteria were
patients older than 18 years old with sepsis, deﬁned as clinical infection
and acute increase in SOFA score>2, and plasma procalcitonin>0.5ng/
ml. Plasma creatinine and Cystatin C were measured at seven time
points, and eGFR were calculated by the Cockcroft-Gault, MDRD, CKD-
EPI, and eGFRCysC and they were compared to their keGFR equations.
Results: Twenty four patients were recruited so far, of which 10
(41.7%) had AKI. Two patients needed dialysis, and one died. keGFRCr
strongly correlated with eGFRCKD-EPI equation in all patients at all time
points (all r$0.76, p<0.0001). On the other hand, keGFRCr only
correlated well with eGFRMDRD and eGFRCG in AKI patients but less in
patients without AKI. keGFRCysC strongly correlated with eGFRCysC in
all patients at all time points (all r$0.89, p<0.0001) keGFRCr and
keGFRCysC were not strongly correlated (min r¼0.29) eGFRCKD-EPI dis-
tribution had the greatest precision depicted by the narrower SD lines.
Similarly, keGFRCysC had higher precision when compared to eGFRCysC.
eGFRMDRD and eGFRCG had the least bias depicted by the mean dif-
ference nearest to zero. Both eGFRCKD-EPI and eGFRCysC distribution
differed signiﬁcantly from the keGFRCr and keGFRCysC, respectively
(Wilcoxon sign rank test, p<0.0001).
Conclusions: The new equation, keGFR strongly correlated with the
eGFR by the CKD-EPI equation with the highest precision. In the
absence of serial plasma creatinine measurement, eGFR is best estimated
by the CKD-EPI equation. eGFR of Cystatin C also correlated well with
its keGFR. Further study would involve analysis of their association
with urinary creatinine clearance.S33
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Peroxiredoxin 3 (PRX3) as a mitochondrial antioxidant regulates
apoptosis in various cancers. Whether tubular PRX3 could predict
recovery of renal function following acute kidney injury (AKI) re-
mains unknown. A retrospective cohort study included 54 hospi-
talized patients who had AKI with biopsy-proven acute tubular
necrosis (ATN). The study outcome was renal function recovery
within 6 months. Of the 54 enrolled patients, 25 (46.3%) had pre-
existing chronic kidney disease (CKD) and 33 (61%) recovered renal
function. Tubular PRX3 expression was higher in patients with ATN
than those without renal function recovery. In multivariate Cox
regression analysis, high PRX3 expression was independently asso-
ciated with a higher probability of renal function recovery (adjusted
hazard ratio 8.99; 95% CI 1.13-71.52, P ¼ 0.04). Furthermore, the
discriminative analysis also showed that high tubular PRX3
expression was associated with a higher probability of renal function
recovery from ATN. Therefore, tubular PRX3 in combination with
conventional predictors can further improve recovery prediction and
may help with risk stratiﬁcation in AKI patients with pre-existing
CKD.
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Introduction: Acute kidney injury (AKI) is an independent risk factor
for mortality in the critically ill patients. While many studies are
conducted in the Intensive Care Unit setting, little is known about AKIS34in the Coronary Care Unit (CCU) patients. Furthermore, data on Asian
patients are limited.
Objective: To determine the prevalence, aetiologies of AKI and clinical
outcomes of these patients.
Methodology: This was a prospective observational study looking at
patients who were admitted in CCU and Cardiac Rehabilitation Ward
(CRW) Kuala Lumpur Hospital from February 2017 to April 2017. AKI
was deﬁned by increase in serum creatinine > 0.3mg/dL (26.5mmol/L)
within 48 hours.
Results: There were 195 admissions; of which 22 (11.3%) patients
fulﬁlled criteria for developing AKI while in CCU and CRW. Two thirds
were male; mean age was 53.4 years (SD 13.4). Heart failure was the
main diagnosis of admission (68.2%) therefore accounted for the most
common aetiology of AKI (72.7%). Although AKI resolved in 15 pa-
tients (68.2%), only 14 (63.6%) survived the hospitalisation. All 8
patients who died were male (p¼0.022). Comparing patients who sur-
vived and died, length of hospital stay was longer (8 vs 19.5 days,
p¼0.05), glomerular ﬁltration rate was lower (27.5 vs 18.3 ml/min,
p¼0.026) and more patients required renal replacement therapy
(p¼0.01) in the mortality group. Conversely, there were no associations
between survival of the patients with mechanical ventilation, inotropic
support and use of medications like renin angiotensin system blockers
and diuretics.
Conclusion: AKI is common and has high mortality rate. Limited by the
small sample size due to short duration, this study provides an early
insight into the prevalence, aetiologies and risk factors for AKI in CCU
patients.071
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Background: Angiopoietin-2(ang-2), a circulating antagonistic ligand of
the endothelial-speciﬁc Tie2 receptor, is a potential marker of endo-
thelial vascular permeability. This study aimed to evaluate the role of
serum ang-2 in critically ill patients with acute kidney injury requiring
continuous renal replacement therapy (CRRT).
Method: This study was a substudy of a previous multicenter ran-
domized controlled trial. Blood samples were collected on day 0, 3, and
7 after inception of CRRT for measurement of serum circulating ang-2
by enzyme-linked immunoassay. We determined association between
serum ang-2 concentrations and mortality, renal recovery, and ﬂuid
overload and generated a receiver operating characteristic curve for
plasma ang-2 and 28-day mortality.
Results: Eighty-seven patients were recruited in the study. Forty-ﬁve
(51.7%) were male, with mean age 66.5  15.8 years. Seventy-three
(83.9%) patients received continuous renal replacement therapy. The
initial median levels of serum angiopoietin-2 were 20,540 ng/mL,
interquartile range [IQR] 11,388 to 39,326 ng/mL. Serum ang-2 were
signiﬁcantly elevated in non-survivors than in survivors at day 0, 3,
and 7. In univariate analysis, serum ang-2 correlated with mortality,
but not AKI staging, ﬂuid overload, or renal recovery. In multivariable
analysis, high levels of serum ang-2 concentrations were predictive of
28-day mortality adjusted for SOFA score, plasma neutrophil gelatins-
associated lipocalin (NGAL) levels, and serum NT-proBNP.
Conclusion: Serum ang-2 is an independent predictor of mortality in
acute kidney injury patients requiring continuous renal replacement
therapy.Kidney International Reports (2017) 2, S1–S41
